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3C (3C protease, 3Cpro) 蛋白酶在 EV71 病毒蛋白的成熟过程中起着关键作
用，3C蛋白酶还能作用于宿主细胞内的多种转录因子以及细胞因子，抑制宿主












3D聚合酶（3D polymerase, 3Dpol）是 RNA 依赖的 RNA聚合酶（RdRP）是




































The structure-based design of inhibitors in this thesis is comprised of two parts
targeting 1) 3C protease from enterovirus 71, and 2) 3D polymerase from
Coxsachivirus B3.
1) Hand-foot-mouth disease (HFMD) is a global infectious diseases caused by
enteroviruses. In recent years, its morbidity in China has increased significantly.
Among the causative agents of HFMD, enterovirus 71 (EV71) is the main one. This
virus can lead to serious neurological complications, and even lead to death. It is of
great importance to find treatment for HFMD.
3C protease plays a key role in the maturation of EV71 proteins. 3C protease can
also act on a variety of transcription factors and cytokines in host cells, inhibit the
expression of host protein and interfere with the immune mechanisms of the host. In
addition, 3C protease is with RNA binding activity and play a role in virus replication.
3C protease is a significant target for the design and development of therapeutics.
In this project, we screened a drug library with 3C protease as the target. The
complex structures of 3C protease and small molecule fragments were analyzed by
X-ray crystallography and a compound bound to the RNA binding region of 3C
protease was identified, which laid the foundation for the fragment-based drug design.
2) Viral myocarditis is caused by viruses that can damage myocardium. Currently,
domestic VMC mortality rates were on the rise. Among the enterovirus,
Coxsackievirus B3 is an important pathogen in viral myocarditis. CVB3 can also
induce the injury or death of human pancreatic islet β-cells, and it is thought to be
associated with type I adolescent diabetes or insulin-independent diabetes mellitus.
3Dpol is an RNA-dependent RNA polymerase (RdRP) and vital to the life cycle
of the RNA virus. 3Dpol is responsible for the initial negative and subsequent positive
strand RNA synthesis, and is important to the viral replication and viability. The 3Dpol















for the development of antiviral drugs.
To establish a system for structure-based drug design and development, we used
technologies of molecular cloning, protein expression and purification to obtain the
proteins and the crystals of 3Dpol were made. However, only a small portion of the
crystals diffracted X-ray to high resolution. Further optimization was needed to
crystallize 3Dpol in a consistent fashion for the drug design and development.
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手足口病( Hand, foot and mouth disease，HFMD )，是一种多发生于婴幼儿中
的传染病，该病是由肠道病毒感染导致的。1957 年该病的流行在新西兰首次被



























Degree papers are in the “Xiamen University Electronic Theses and Dissertations Database”. Full
texts are available in the following ways: 
1. If your library is a CALIS member libraries, please log on http://etd.calis.edu.cn/ and submit
requests online, or consult the interlibrary loan department in your library. 
2. For users of non-CALIS member libraries, please mail to etd@xmu.edu.cn for delivery details.
厦
门
大
学
博
硕
士
论
文
摘
要
库
